Latanoprost in port wine stain related paediatric glaucoma

British Journal of Ophthalmology

Volumn 87, Issue 9, 2003, Pages 1091-1093

  Ong, T ^a   Chia, A ^a,b   Nischal, K K ^a,b,c  

^a Hospital for Children NHS Trust   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Hospital for Sick Children   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAXOLOL; BRIMONIDINE; DIPIVEFRINE; LATANOPROST; PILOCARPINE;

ADJUVANT THERAPY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; NEVUS FLAMMEUS; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ANTIHYPERTENSIVE AGENTS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; GLAUCOMA; HUMANS; INFANT; INTRAOCULAR PRESSURE; PORT-WINE STAIN; PROSTAGLANDINS F, SYNTHETIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0042358690     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.9.1091     Document Type: Review

References (30)

1. Tripathi BJ, Tripathi RC, Cibis GW. Sturge-Weber syndrome. Encephalotrigeminal angiomatosis. In: Gold DH, Weingeist TA, eds. The eye in systemic disease. Philadelphia: JB Lippincott, 1990;148:443-7.
2. Duke-Elder S, Jay B. Encephalo- (oculo)-facial angiomatosis (the Sturge Weber syndrome). In: Duke-Elder S, ed. System of ophthalmology. Diseases of the lens and vitreous; glaucoma and hypotony. Vol 11. London: Henry Kimpton, 1969:637-40.
3. Sullivan TJ, Clarke MP, Morin JD. The ocular manifestations of the Sturge-Weber syndrome. J Pediatr Ophthalmol Strabismus 1992;29:349-6.
4. Phelps CD. The pathogenesis of glaucoma in Sturge-Weber syndrome. Ophthalmology 1978;85:276-86.
5. Patelska B, Greenfield DS, Liebmann JM, et al. Latanoprost for uncontrolled glaucoma in a compassionate case protocol. Am J Ophthalmol 1997;124:279-86.
6. Hedman K, Alm A. A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol. Eur J Ophthalmol 2000;10:95-104.
7. Brown SM. Increased iris pigment in a child due to latanoprost. Arch Ophthalmol 1998;116:1683-4 (erratum Arch Ophthalmol 1999;117:751).
8. Schmidtborn F. Systemic side effects of Latanoprost therapy in children with aniridia and glaucoma. Ophthalmologe 1998;95:633-4.
9. Enyedi LB, Freedman SF, Buckley EG. The effectiveness of latanoprost for the treatment of pediatric glaucoma. J AAPOS 1999;1:33-9.
10. Altuna JC, Greenfield DS, Wand M, et al. Latanoprost in glaucoma associated with Sturge-Weber syndrome: benefits and side effects. J Glaucoma 1999;8:199-203.
11. Yang CB, Freedman SF, Myers JS, et al. Use of Latanoprost in the treatment of glaucoma associated with Sturge-Weber Syndrome. Am J Ophthalmol 1998;126:600-2.
12. Cibis GW, Tripathi RC, Tripathi BJ. Glaucoma in Sturge-Weber syndrome. Ophthalmology 1984;91:1061-71.
13. Taylor RH, Ainsworth JR, Evans AR, et al. The epidemiology of pediatric glaucoma: the Toronto experience. J AAPOS 1999,3:308-15.
14. Awad AH, Mullaney PB, Al-Mesfer S, et al. Glaucoma in Sturge-Weber syndrome. J AAPOS 1999,3:40-5.
15. Sujansky E, Conradi S. Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children. J Child Neurol 1995,10:49-58.
16. Morlet N, Goldberg I. Sturge-Weber syndrome and secondary glaucoma. Aust N Z J Ophthalmol 1993,21:271-2.
17. Iwach AG, Hoskins HD, Hetherington J, et al. Analysis of surgical and medical management of glaucoma in Sturge Weber syndrome. Ophtholmology 1990;97:904-9.
18. McMahon CD, Hetherington J, Hoskins HD, et al. Timolol and pediatric glaucomas. Ophthalmology 1981;88:249-52.
19. Van Emelen C, Goethals M, Dralands L, et al. Treatment of glaucoma in children with Sturge-Weber syndrome. J Pediatr Ophthalmol Strabismus 2000;37:29-34.
20. Hamush NG, Coleman AL, Wilson MR. Ahmed glaucoma valve implant for management of glaucoma in Sturge-Weber syndrome. Am J Ophthalmol 1999;128:758-60.
21. Christensen GR, Records RE. Glaucoma and expulsive haemorrhage mechanisms in the Sturge Weber syndrome. Ophthalmology 1979;86:1360-6.
22. Mandal AK. Primary combined trabeculotomy-trabeculeculectomy for early-onset glaucoma in Sturge-Weber syndrome. Ophthalmology 1999;106:1621-7.
23. Duman A, Ogun CO, Okesli S. The effect on intraocular pressure of tracheal intubation or laryngeal mask insertion during sevoflurane anaesthesia in children without the use of muscle relaxants. Paediatr Anaesth 2001;11:421-4.
24. Rudolph P. The intraocular pressure during ketamine and halothane anaesthesia Anaesthesist 1974;23:245-8.
25. Degenne S, Benck P, Gerhard JP, et al. [Alterations in intraocular pressure in children examined by Goldmann's applanation tonometer under general anesthesia.] Arch Ophtalmol Rev Gen Ophtalmol 1968;128:359-74.
26. Poyer JF, Millar C, Kaufman PL. Prostaglandin F2 alpha effects on isolated rhesus monkey ciliary muscle. Invest Ophthalmol Vis Sci 1995;36:2461-5.
27. Lindsey JD, Kashiwagi K, Kashiwagi F, et al. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci 1997;38:2214-23
28. Wu Dunn D. The effect of mechanical strain on matrix metalloproteinase production by bovine trabecular meshwork cells. Curr Eye Res 2001;22:394-7.
29. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Exp Eye Res 1998;67:179-91.
30. Lindsey JD, Kashiwagi K, Kashiwagi F, et al. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implication for uveoscleral outflow. Surv Ophthalmol 1997;41(suppl):S53-9.